NASDAQ:VXRT   Vaxart, Inc. - Common Stock
I'll be purchasing calls for a $20 Strike expiring Jan.15th 2021. The CDC recently informed states to be ready to distribute Covid 19 vaccines by November 1st. With Vaxart still needing FDA approval they could see a major run soon.

Things to Keep in Mind
Vaxart is the only COVID-19 vaccine developer, among those mentioned in operation wrap speed, that has"next generation" oral tablet vaccines. According to Vaxart, its oral vaccines have been shown to be safe and well-tolerated and have the potential to generate a broad and durable immunity (systemic and mucosal), having been safely trialed in >460 humans, across 3 viral diseases.


免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。